Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Stock Traders Daily
$20.00
Provider: New Constructs, LLC
$25.00
Provider: Jefferson Research
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

C R Bard Inc To Pay $48 Million To Settle Kickback Allegations-Reuters


Monday, 13 May 2013 06:44pm EDT 

Reuters reported that C R Bard Inc will pay about $48.3 million to resolve allegations it made illegal payments to hospitals and physicians to entice them to buy its radiation treatment for prostate cancer, the Justice Department (DOJ) said. The illegal payments allegedly took the form of grants, rebates, conference fees, marketing assistance and free medical equipment that Bard provided between 1998 and 2006 to customers who used its brachytherapy seeds to treat prostate cancer, DOJ said. 

Company Quote

169.5
-2.08 -1.21%
19 Dec 2014